Neonode Inc. (NEON)
NASDAQ: NEON · Real-Time Price · USD
22.51
-0.23 (-1.01%)
Aug 13, 2025, 4:00 PM - Market closed
Theseus Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 1.98 | 3.11 | 3.83 | 5.67 | 5.84 | 5.98 | Upgrade | |
Revenue Growth (YoY) | -45.16% | -18.83% | -32.47% | -2.84% | -2.47% | -9.96% | Upgrade |
Cost of Revenue | -0.37 | 0.12 | 0.01 | 0.8 | 0.96 | 1.08 | Upgrade |
Gross Profit | 2.35 | 2.99 | 3.82 | 4.87 | 4.88 | 4.91 | Upgrade |
Selling, General & Admin | 5.66 | 6.1 | 5.72 | 6.19 | 8.44 | 6.96 | Upgrade |
Research & Development | 3.62 | 3.44 | 3.83 | 3.96 | 3.55 | 4.14 | Upgrade |
Operating Expenses | 9.28 | 9.54 | 9.55 | 10.15 | 11.99 | 11.1 | Upgrade |
Operating Income | -6.93 | -6.55 | -5.74 | -5.29 | -7.11 | -6.19 | Upgrade |
Interest Expense | - | - | - | - | -0.02 | -0.03 | Upgrade |
Interest & Investment Income | 0.37 | 0.69 | 0.74 | 0.1 | - | - | Upgrade |
Other Non Operating Income (Expenses) | 0.3 | - | - | 0.02 | - | -0.01 | Upgrade |
EBT Excluding Unusual Items | -6.26 | -5.86 | -5 | -5.17 | -7.12 | -6.22 | Upgrade |
Pretax Income | -6.26 | -5.86 | -5 | -5.17 | -7.12 | -6.22 | Upgrade |
Income Tax Expense | -0.02 | 0.02 | 0.12 | 0.12 | 0.15 | 0.06 | Upgrade |
Earnings From Continuing Operations | -6.25 | -5.88 | -5.12 | -5.28 | -7.27 | -6.28 | Upgrade |
Earnings From Discontinued Operations | -0.04 | -0.59 | -5.01 | - | - | - | Upgrade |
Net Income to Company | -6.29 | -6.47 | -10.12 | -5.28 | -7.27 | -6.28 | Upgrade |
Minority Interest in Earnings | - | - | - | 0.4 | 0.82 | 0.68 | Upgrade |
Net Income | -6.29 | -6.47 | -10.12 | -4.88 | -6.45 | -5.61 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.03 | Upgrade |
Net Income to Common | -6.29 | -6.47 | -10.12 | -4.88 | -6.45 | -5.64 | Upgrade |
Shares Outstanding (Basic) | 17 | 16 | 15 | 14 | 12 | 10 | Upgrade |
Shares Outstanding (Diluted) | 17 | 16 | 15 | 14 | 12 | 10 | Upgrade |
Shares Change (YoY) | 7.98% | 3.60% | 12.40% | 14.49% | 19.20% | 12.95% | Upgrade |
EPS (Basic) | -0.38 | -0.41 | -0.66 | -0.36 | -0.54 | -0.56 | Upgrade |
EPS (Diluted) | -0.38 | -0.41 | -0.66 | -0.36 | -0.54 | -0.56 | Upgrade |
Free Cash Flow | -5.58 | -5.63 | -6.43 | -6.86 | -7.75 | -5.81 | Upgrade |
Free Cash Flow Per Share | -0.34 | -0.35 | -0.42 | -0.50 | -0.65 | -0.58 | Upgrade |
Gross Margin | 118.72% | 96.27% | 99.69% | 85.82% | 83.64% | 81.98% | Upgrade |
Operating Margin | -349.60% | -210.65% | -149.83% | -93.23% | -121.78% | -103.46% | Upgrade |
Profit Margin | -317.25% | -208.04% | -264.38% | -86.12% | -110.52% | -94.22% | Upgrade |
Free Cash Flow Margin | -281.63% | -181.11% | -167.96% | -120.99% | -132.71% | -97.13% | Upgrade |
EBITDA | -6.89 | -6.49 | -5.64 | -5.17 | -6.48 | -5.42 | Upgrade |
EBITDA Margin | - | -208.78% | -147.35% | -91.11% | -110.95% | -90.64% | Upgrade |
D&A For EBITDA | 0.04 | 0.06 | 0.1 | 0.12 | 0.63 | 0.77 | Upgrade |
EBIT | -6.93 | -6.55 | -5.74 | -5.29 | -7.11 | -6.19 | Upgrade |
EBIT Margin | - | -210.65% | -149.83% | -93.23% | -121.78% | -103.46% | Upgrade |
Revenue as Reported | 1.98 | 3.11 | 3.83 | 5.67 | 5.84 | 5.98 | Upgrade |
Advertising Expenses | - | - | - | 0.16 | 0.21 | 0.07 | Upgrade |
Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.